Back to ACAD
WESPAC Advisors SoCal, LLC → ACAD
WESPAC Advisors SoCal, LLC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$10.1M
Q3 2026
Peak value
$17.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $17.2M |
| Q4 2025 | $17.7M |
| Q1 2026 | $9.8M |
| Q2 2026 | $10.2M |
| Q3 2026 | $10.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $10.1M | 57.1K | — | — |
| Q2 2026 | $10.2M | 58.2K | — | — |
| Q1 2026 | $9.8M | 59.7K | — | — |
| Q4 2025 | $17.7M | 98.8K | — | — |
| Q3 2025 | $17.2M | 97.4K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M